Difference between revisions of "Part:BBa K4165113"
Omnia Alaa11 (Talk | contribs) |
Omnia Alaa11 (Talk | contribs) |
||
(One intermediate revision by one other user not shown) | |||
Line 14: | Line 14: | ||
<partinfo>BBa_K4165113 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4165113 SequenceAndFeatures</partinfo> | ||
− | === | + | ===Dry lab characterizations=== |
+ | ===Modeling=== | ||
Got score of 4 out of 6 in our Quality assessment code after modeling by AlphaFold2.0 | Got score of 4 out of 6 in our Quality assessment code after modeling by AlphaFold2.0 | ||
+ | |||
<html> | <html> | ||
Line 48: | Line 50: | ||
</html> | </html> | ||
− | + | ||
+ | |||
<html> | <html> | ||
<p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/htra1-bp/h1s.jpg" style="margin-left:200px;" alt="" width="500" /></p> | <p><img src="https://static.igem.wiki/teams/4165/wiki/parts-registry/htra1-bp/h1s.jpg" style="margin-left:200px;" alt="" width="500" /></p> |
Latest revision as of 09:07, 13 October 2022
HTRA Binding Peptide 19
part encodes for a synthetic peptide that binds to the PDZ domain of HTRA1 protein
Usage and Biology
A reversed sequence of a high affinity binding peptide is proposed for binding to the PDZ domain of HTRA1.
We were motivated by our chosen Tau binding peptide since it was the inverted sequence of a high affinity peptide that shown better affinity, so we decided to try it with our HTRA1 BP.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Dry lab characterizations
Modeling
Got score of 4 out of 6 in our Quality assessment code after modeling by AlphaFold2.0
cbeta_deviations | clashscore | molprobity | ramachandran_favored | ramachandran_outliers | Qmean_4 | Qmean_6 |
---|---|---|---|---|---|---|
0 | 179.69 | 3.76 | 33.33 | 66.67 | -1.89913 | -0.60712 |
Figure 1.: 3D Model of H1S peptide Modelled by AlphaFold2.0 displayed in Pymol.
References
Dammers, C., Yolcu, D., Kukuk, L., Willbold, D., Pickhardt, M., Mandelkow, E., ... & Funke, S. A. (2016). Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease. PLoS One, 11(12), e0167432.